Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SpaceX (SPCX) vs Twist Bioscience Corp (TWST) Price & Performance

SpaceXTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

SpaceX vs Twist Bioscience Corp — how do they compare? SpaceX trades at $123.46 (market cap $1.58T), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: SpaceX is far larger — about 289.9× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.

SPCXTWST
Market Cap
$1.58T$5.45B
Sector
TechnologyHealth
52-Week High
$202.09$102.88
52-Week Low
$119.85$24.16
Enterprise Value
$1.59T$5.37B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SpaceX

SPCX trades at $119.85, down 3.34% today and 45% below its post-IPO high, with a bearish technical signal despite oversold RSI readings. The company reported Q1 2026 EPS of -$1.19, missing estimates by 260%, while revenue grew to $18.67B in 2025. SpaceX faces significant valuation concerns with a P/S of 84 and negative profitability metrics, though analyst consensus remains 100% buy-rated with a $237.78 price target representing 98% upside potential.

The stock presents high-risk/high-reward potential with strong institutional support but faces near-term headwinds from August lockup expirations and persistent losses. Long-term growth depends on Starlink expansion and AI contract wins, though current fundamentals don't justify the premium valuation. Investors must weigh analyst optimism against cash burn and execution risks in the competitive space sector.

Twist Bioscience Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.

Read more on SPCX

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST